1,179
Views
25
CrossRef citations to date
0
Altmetric
Article

Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis

, , &
Pages 1-11 | Received 07 Feb 2014, Accepted 24 Feb 2014, Published online: 25 Jul 2014

References

  • Ahn B, Ohshima H. 2001. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res. 61:8357–8360.
  • Arai M, Sasaki A, Saito N, Nakazato Y. 2005. Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system. Pathol Int. 55:122–129.
  • Austin EB, Robins RA, Durrant LG, Price MR, Baldwin RW. 1998. Human monoclonal anti- idiotypic antibody to the tumor-associated antibody 791T/36. Immunology. 67:525.
  • Baricault L, Denariaz G, Houri JJ, Bouley C, Sapin C, Trugnan G. 1995. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis. 16:245–252.
  • Bhathena J, Kulamarva A, Urbanska AM, Martoni C, Prakash S. 2007. Microencapsulated bacterial cells can be used to produce the enzyme feruloyl esterase: preparation and in-vitro analysis. Appl Microbiol Biotechnol. 75:1023–1029.
  • Bhathena J, Kulamarva A, Martoni C, Urbanska AM, Prakash S. 2008. Preparation and in vitro analysis of microencapsulated live Lactobacillus fermentum 11976 for augmentation of feruloyl esterase in the gastrointestinal tract. Biotechnol Appl Biochem. 50:1–9.
  • Chan TA, Morin PJ, Vogelstein B, Kinzer KW. 1998. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc Natl Acad Sci. 95:681–686.
  • Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature. 420:860–867.
  • Deckert-Schluter M, Rang A, Wiestler OD. 1998. Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system. Acta Neuropathol. 96:157–162.
  • Donoghue S, Baden HS, Lauder I, Sobolewski S, Pringle JH. 1999. Immunohistochemical localization of caspase-3 correlates with clinical outcome in B-cell diffuse large-cell lymphoma. Cancer Res. 59:5386–5391.
  • Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. 2005. Experimental models of inflammatory bowel disease reveal innate, adaptice, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 206:260–276.
  • Fooks LJ, Gibson GR. 2002. Probiotics as modulators of the gut flora. Br J Nutr. 88:S39–49.
  • Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. 2007. Molecular- phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci. 104:13780–13785.
  • Frank DN, Pace NR. 2008. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol. 24:4–10.
  • Galdeano CM, Perdigon G. 2006. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol. 13:219–226.
  • Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, et al. 2003. Prophylaxis of puchitis onset with probiotic theraphy: a double-blind, placebo-controlled trial. Gastroenterology. 124:1202–1209.
  • Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, et al. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-assciated cancer. Cancer Cell. 15:103–113.
  • Grivennikov S, Wang K, Mucida D, Stewart CA, Schnabl B, et al. 2012. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17 mediated tumor growth. Nature. 491:254–258.
  • Haggar FA, Boushey RP. 2009. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 22:191–197.
  • Hall C, Youngs D, Keighley MR. 1992. Crypt cell production rates at various sites around the colon in Wistar rats and humans. Gut. 33:1528–1531.
  • Heijstek MW, Kranenburg O, Borel Rinkes IH. 2005. Mouse models of colorectal cancer and liver metastases. Dig Surg. 22:16–25.
  • Heyman M, Corthier G, Petit A, Meslin JC, Moreau C, Desjeux JF. 1987. Intestinal absorption of macromolecules during viral enteritis: an experimental study on rotavirus-infected conventional and germ-free mice. Pediatr Res. 22:72–78.
  • Iannitti T, Palmieri B. 2010. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 29:701–725.
  • Iyer C, Kosters A, Sethi G, Kunnumakkara AB, Versalovic J. 2008. Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NK-kappaB and MAPK signaling. Cell Microbiology. 10:1442–1452.
  • Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. 2013. CXCR2-expressing myeloid- derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 24: 631–644.
  • Konstantinidou A, Korkolopoulou P, Patsouris E, Mahera H, Hranioti S, et al. 2001. Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas. J Neurooncol. 55:1–9.
  • Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. 1986. Effects of topical 5-aminosalicilic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of recum in relapsing ulcerative colitis. Gastroenterology. 91:837–84.
  • Le Leu RK, Brown IL, Hu Y, Bird AR, Jackson M, Esterman A, Young GP. 2005. A symbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr. 135:996–1001.
  • Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP. 2010. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis. 31:246–251.
  • Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H. 1998. CD8 + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 58(16):3491–4.
  • Parkin DM, Bray F, Ferlay J, Pisani P. 2001. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 94:153–156.
  • Potten CS, Kellett M, Rew DA, Roberts SA. 1992. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli. Gut. 33:524–529
  • Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464:59–65.
  • Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, et al. 1998. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology. 115:297–306.
  • Strober W, Fuss I, Mannon P. 2007. The fundamental basis of inflammatory bowel disease. J Clin Invest. 117:514–552.
  • Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, et al. 1992. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 256:668–670.
  • Sutherland L, Singleton J, Sessions J, Hanauer S, Krawitt E, et al. 1991. Double blind, placebo controlled trial of metronidazole in Crohns's disease. Gut. 32:1071–1075.
  • Tsujii M, DuBois RN. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell. 83:493–501.
  • Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, et al. 2008. Overexpression of interleukin-1 beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 14:408–419.
  • Ucello M, Malaguarnera G, Basile F, D'agata V, Malaguarnera M, Bertino G, et al. 2012. Potential role of probiotics on colorectal cancer prevention. BMC Surgery. 12:S35.
  • Urbanska AM, Bhathena J, Prakash S. 2007. Live encapsulated Lactobacillus acidophilus cells in yogurt for therapeutic oral delivery: preparation and in vitro analysis of alginate-chitosan microcapsules. Can J Physiol Pharmacol. 85:884–893.
  • Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. 1997. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA. 94:1402–1407.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.